Prospectus

Ensysce Biosciences, Inc. Filed 2022-08-02 Acc 0001493152-22-020948

Documents 1

2022-08-04 EFFECT Notice of Effectiveness
2022-08-02 CORRESP Correspondence Between Filers and SEC Staff
2022-08-02 424B3 Prospectus
2022-08-02 424B3 Prospectus
2022-08-02 8-K Material agreement · New debt or obligation · Unregistered share sale
2022-07-29 DEF 14A Proxy Statement
2022-06-21 424B3 Prospectus

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading form424b3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…